previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | next
| CSGID ID | Priority | Locus Tag | NCBI GI | Gene Name |
Common Name | Sequence Length |
Comment | Project | Homolog PDB ID |
Homolog Sequence Identity |
Target Organism | TIGR Main Role | TIGR Subrole | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDP00741 | 1 | SACOL1253 | 57285992 | ffh | signal recognition particle protein | 455 | Drug Target Function | March 2008 | 2J28 | 49% | Staphylococcus aureus | Protein fate | Protein and peptide secretion and trafficking | |||||||||||||||||
| IDP00737 | 1 | SACOL0993 | 57284367 | oppD | oligopeptide ABC transporter, ATP-bindin... | 360 | Drug Target Function | March 2008 | 1B0U | 25% | Staphylococcus aureus | Transport and binding proteins | Amino acids, peptides and amines | |||||||||||||||||
| IDP00638 | 1 | SACOL2736 | 57285290 | gidB | glucose-inhibited division protein B | 239 | Drug Target Function | March 2008 | 1XDZ | 63.2% | Staphylococcus aureus | Unknown function | General | |||||||||||||||||
| IDP00658 | 1 | SACOL0801 | 57285762 | murB | UDP-N-acetylenolpyruvoylglucosamine redu... | 307 | Drug Target Function | March 2008 | 1HSK | 99.3% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00804 | 1 | SACOL1787 | 57286221 | bifunctional 3-deoxy-7-phosphoheptulonat... | 363 | Drug Target Function | March 2008 | 1RZM | 39.9% | Staphylococcus aureus | Amino acid biosynthesis | Aromatic amino acid family | ||||||||||||||||||
| IDP00832 | 1 | SACOL2612 | 57286517 | hydrolase, CocE/NonD family | 560 | Drug Target Function | March 2008 | 1JU3 | 27% | Staphylococcus aureus | Unknown function | Enzymes of unknown specificity | ||||||||||||||||||
| IDP00657 | 1 | SACOL0761 | 57285726 | nagA | N-acetylglucosamine-6-phosphate deacetyl... | 393 | Drug Target Function | March 2008 | 2VHL | 46.3% | Staphylococcus aureus | Central intermediary metabolism | Amino sugars | |||||||||||||||||
| IDP00697 | 1 | SACOL2563 | 57285245 | ATP-dependent Clp protease, putative | 701 | Drug Target Function | March 2008 | 1QVR | 43.2% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00605 | 1 | SACOL1745 | 57284754 | pyk | pyruvate kinase | 585 | Drug Target Function | March 2008 | 2E28 | 60% | Staphylococcus aureus | Energy metabolism | Glycolysis/gluconeogenesis | |||||||||||||||||
| IDP00685 | 1 | SACOL2016 | 57284887 | groEL | chaperonin GroEL | 538 | Drug Target Function | March 2008 | 1IOK | 59.7% | Staphylococcus aureus | Protein fate | Protein folding and stabilization | |||||||||||||||||
| IDP00739 | 1 | SACOL1063 | 57284433 | acetyltransferase, GNAT family | 144 | Drug Target Function | March 2008 | 1Q2Y | 40.3% | Staphylococcus aureus | Unknown function | Enzymes of unknown specificity | ||||||||||||||||||
| IDP00411 | 1 | YPO0161 | 16120504 | nirB | nitrite reductase | 848 | Drug Target Function | March 2008 | 1D7Y | 13.6% | Yersinia pestis | Energy metabolism | Electron transport | |||||||||||||||||
| IDP00573 | 1 | YPO3991 | 16124118 | putative insulinase family protease | 499 | Drug Target Function | March 2008 | 1HR6 | 12% | Yersinia pestis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01076 | 1 | STM4120 | 16767385 | argE | acetylornithine deacetylase | 383 | Drug Target Function | March 2008 | 3CT9 | 25.1% | Salmonella typhimurium | Amino acid biosynthesis | Glutamate family | |||||||||||||||||
| IDP01038 | 1 | STM2929 | 16766235 | ispF | 2-C-methyl-D-erythritol 2,4-cyclodiphosp... | 159 | Drug Target Function | March 2008 | 1GX1 | 98.1% | Salmonella typhimurium | Biosynthesis of cofactors, prosthetic groups, and carriers | Other | |||||||||||||||||
| IDP00986 | 1 | STM2106 | 16765436 | wcaI | predicted glycosyl transferase | 407 | Drug Target Function | March 2008 | Salmonella typhimurium | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||||
| IDP00419 | 1 | YPO0678 | 16121001 | putative iron-containing alcohol dehydro... | 385 | Drug Target Function | March 2008 | 1OJ7 | 76.9% | Yersinia pestis | Central intermediary metabolism | Other | ||||||||||||||||||
| IDP00747 | 1 | SACOL1768 | 57286203 | GAF domain protein | 154 | Drug Target Function | March 2008 | 1VHM | 51.3% | Staphylococcus aureus | Unknown function | General | ||||||||||||||||||
| IDP00808 | 1 | SACOL1868 | 57284789 | splB | serine protease SplB | 240 | Drug Target Function | March 2008 | 2VID | 85% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP00692 | 1 | SACOL2128 | 57286344 | pdp | pyrimidine-nucleoside phosphorylase | 433 | Drug Target Function | March 2008 | 1BRW | 68.4% | Staphylococcus aureus | Purines, pyrimidines, nucleosides, and nucleotides | Other | |||||||||||||||||
| IDP00759 | 1 | SACOL0188 | 57285390 | ggt | gamma-glutamyltranspeptidase | 668 | Drug Target Function | March 2008 | 2E0W | 27.8% | Staphylococcus aureus | Biosynthesis of cofactors, prosthetic groups, and carriers | Glutathione and analogs | |||||||||||||||||
| IDP00805 | 1 | SACOL1801 | 57286235 | dipeptidase PepV | 469 | Drug Target Function | March 2008 | 1LFW | 35.2% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00778 | 1 | SACOL0668 | 57284264 | hydrolase, alpha/beta hydrolase fold fam... | 266 | Drug Target Function | March 2008 | 1VA4 | 27.4% | Staphylococcus aureus | Unknown function | Enzymes of unknown specificity | ||||||||||||||||||
| IDP00749 | 1 | SACOL2105 | 57286321 | glyA | serine hydroxymethyltransferase | 412 | Drug Target Function | March 2008 | 1KKJ | 70.9% | Staphylococcus aureus | Amino acid biosynthesis | Serine family | |||||||||||||||||
| IDP00485 | 1 | YPO1455 | 16121730 | putative beta-ketoacyl-[acyl-carrier-pro... | 427 | Drug Target Function | March 2008 | 1J3N | 32.6% | Yersinia pestis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP00324 | 1 | Cj1366c | 15792689 | glmS | D-fructose-6-phosphate amidotransferase ... | 598 | Drug Target Function | March 2008 | 1JXA | 42.3% | Campylobacter jejuni | Unclassified | Unclassified | |||||||||||||||||
| IDP00816 | 1 | SACOL2061 | 57284929 | acpS | holo-(acyl-carrier-protein) synthase | 119 | Drug Target Function | March 2008 | 3F09 | 100% | Staphylococcus aureus | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00683 | 1 | SACOL1795 | 57286229 | pepA1 | glutamyl aminopeptidase | 358 | Drug Target Function | March 2008 | 1VHE | 37.4% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP00751 | 1 | SACOL2117 | 57286333 | fbaA | fructose-bisphosphate aldolase | 286 | Drug Target Function | March 2008 | 2FJK | 48.6% | Staphylococcus aureus | Energy metabolism | Glycolysis/gluconeogenesis | |||||||||||||||||
| IDP00308 | 1 | CBU_0288 | 29653640 | coaD | phosphopantetheine adenylyltransferase | 159 | Drug Target Function | March 2008 | 1OD6 | 47.2% | Coxiella burnetii | Biosynthesis of cofactors, prosthetic groups, and carriers | Pantothenate and coenzyme A | |||||||||||||||||
| IDP00578 | 1 | YPO3553 | 16123697 | elbB | isoprenoid biosynthesis protein with ami... | 217 | Drug Target Function | March 2008 | 1OY1 | 63.6% | Yersinia pestis | Unknown function | General | |||||||||||||||||
| IDP00311 | 1 | CBU_0494 | 29653836 | fabD | malonyl CoA-acyl carrier protein transac... | 313 | Drug Target Function | March 2008 | 1MLA | 54% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00304 | 1 | CBU_0038 | 29653401 | 3-oxoacyl-(acyl-carrier-protein) synthas... | 327 | Drug Target Function | March 2008 | 1UB7 | 29.4% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP00320 | 1 | CBU_0550 | 29653890 | pbpA | penicillin-binding protein 2 | 612 | Drug Target Function | March 2008 | 1MWR | 25.3% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00312 | 1 | CBU_0497 | 29653839 | fabF | 3-oxoacyl-acyl carrier protein synthase ... | 414 | Drug Target Function | March 2008 | 1B3N | 60.1% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00306 | 1 | CBU_0137 | 29653495 | murB | UDP-N-acetylenolpyruvoylglucosamine redu... | 316 | Drug Target Function | March 2008 | 1HSK | 34.5% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00307 | 1 | CBU_0142 | 29653500 | lpxC | UDP-3-0-acyl N-acetylglucosamine deacety... | 303 | Drug Target Function | March 2008 | 2VES | 65.7% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP00314 | 1 | CBU_0751 | 29654085 | murA | UDP-N-acetylglucosamine 1-carboxyvinyltr... | 434 | Drug Target Function | March 2008 | 1EJC | 56.9% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00310 | 1 | CBU_0493 | 29653835 | fabH | 3-oxoacyl-(acyl-carrier-protein) synthas... | 319 | Drug Target Function | March 2008 | 1HN9 | 54.5% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00317 | 1 | CBU_1887 | 29655172 | ponA | penicillin-binding protein 1A | 793 | Drug Target Function | March 2008 | 2OLU | 23.2% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00303 | 1 | CBU_0035 | 29653398 | beta-ketoacyl synthase | 424 | Drug Target Function | March 2008 | 3E60 | 37.3% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP00315 | 1 | CBU_0874 | 29654200 | aroC | chorismate synthase | 352 | Drug Target Function | March 2008 | 1R52 | 46.6% | Coxiella burnetii | Amino acid biosynthesis | Aromatic amino acid family | |||||||||||||||||
| IDP00302 | 1 | CBU_1155 | 29654460 | trpBF | N-(5'phosphoribosyl)anthranilate isomera... | 600 | Drug Target Function | March 2008 | 1V8Z | 38% | Coxiella burnetii | Amino acid biosynthesis | Aromatic amino acid family | |||||||||||||||||
| IDP00860 | 1 | STM1910 | 16765252 | putative penicillin-binding protein | 623 | Drug Target Function | March 2008 | 1MWR | 24.9% | Salmonella typhimurium | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01493 | 1 | VCA0751 | 161582040 | 3-oxoacyl-(acyl carrier protein) synthas... | 362 | Drug Target Function | March 2008 | 2EBD | 40.9% | Vibrio cholerae | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP00305 | 1 | CBU_0118 | 29653476 | pbpB | penicillin-binding protein 3 | 548 | Drug Target Function | March 2008 | 3EQU | 39.2% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00318 | 1 | CBU_1947 | 29655231 | glmU | UDP-N-acetylglucosamine pyrophosphorylas... | 455 | Drug Target Function | March 2008 | 1HV9 | 51.4% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP00569 | 1 | YPO4016 | 16124139 | hutH | histidine ammonia-lyase | 510 | Drug Target Function | March 2008 | 1B8F | 77.6% | Yersinia pestis | Energy metabolism | Amino acids and amines | |||||||||||||||||
| IDP00330 | 1 | Cj0345 | 15791713 | trpE | putative anthranilate synthase component... | 416 | Drug Target Function | March 2008 | 1QDL | 32% | Campylobacter jejuni | Amino acid biosynthesis | Aromatic amino acid family | |||||||||||||||||
| IDP00313 | 1 | CBU_0647 | 29653985 | ribA | riboflavin biosynthesis protein RibA | 406 | Drug Target Function | March 2008 | 2BZ0 | 27.1% | Coxiella burnetii | Biosynthesis of cofactors, prosthetic groups, and carriers | Riboflavin, FMN, and FAD | |||||||||||||||||
| IDP00527 | 1 | YPO0129 | 16120472 | bioH | putative biotin biosynthesis protein | 258 | Drug Target Function | March 2008 | 1M33 | 63.6% | Yersinia pestis | Biosynthesis of cofactors, prosthetic groups, and carriers | Biotin | |||||||||||||||||
| IDP01059 | 1 | STM3509 | 16766797 | bioH | carboxylesterase BioH | 256 | Drug Target Function | March 2008 | 1M33 | 79.3% | Salmonella typhimurium | Biosynthesis of cofactors, prosthetic groups, and carriers | Biotin | |||||||||||||||||
| IDP01413 | 1 | VC1174 | 15641187 | anthranilate synthase component I | 523 | Drug Target Function | March 2008 | 1I1Q | 59.3% | Vibrio cholerae | Amino acid biosynthesis | Aromatic amino acid family | ||||||||||||||||||
| IDP00316 | 1 | CBU_1152 | 29654458 | trpE | anthranilate synthase component I | 463 | Drug Target Function | March 2008 | 1QDL | 34.3% | Coxiella burnetii | Amino acid biosynthesis | Aromatic amino acid family | |||||||||||||||||
| IDP00670 | 1 | SACOL1212 | 57285955 | pyrB | aspartate carbamoyltransferase catalytic... | 293 | Drug Target Function | March 2008 | 2AT2 | 56% | Staphylococcus aureus | Purines, pyrimidines, nucleosides, and nucleotides | Pyrimidine ribonucleotide biosynthesis | |||||||||||||||||
| IDP00309 | 1 | CBU_0298 | 29653649 | murI | glutamate racemase | 280 | Drug Target Function | March 2008 | 2GZM | 38.2% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00600 | 1 | SACOL0532 | 57285557 | hypothetical protein SACOL0532 | 51 | Drug Target Function | March 2008 | Staphylococcus aureus | 0 | 0 | ||||||||||||||||||||
| IDP01437 | 1 | VC1983 | 15641985 | peptidase, putative | 615 | Drug Target Function | March 2008 | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||||
| IDP00553 | 1 | YPO3939 | 16124067 | glgA | glycogen synthase | 476 | Drug Target Function | March 2008 | 2QZS | 71.4% | Yersinia pestis | Energy metabolism | Biosynthesis and degradation of polysaccharides | |||||||||||||||||
| IDP01373 | 1 | VC0335 | 15640362 | NlpD-related protein | 382 | Drug Target Function | March 2008 | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||||
| IDP01065 | 1 | STM3722 | 16767007 | rfaG | glucosyltransferase I | 374 | Drug Target Function | March 2008 | 2IV7 | 86.4% | Salmonella typhimurium | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP00982 | 1 | STM2062 | 16765392 | dacD | D-alanyl-D-alanine carboxypeptidase | 390 | Drug Target Function | March 2008 | 1NZO | 45.1% | Salmonella typhimurium | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01407 | 1 | VC0947 | 15640963 | D-alanyl-D-alanine carboxypeptidase | 391 | Drug Target Function | March 2008 | 1NZO | 52.2% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00538 | 1 | YPO0070 | 16120421 | cysE | serine acetyltransferase | 273 | Drug Target Function | March 2008 | 1T3D | 86.1% | Yersinia pestis | Amino acid biosynthesis | Serine family | |||||||||||||||||
| IDP00319 | 1 | CBU_2070 | 29655348 | chorismate mutase, putative | 136 | Drug Target Function | March 2008 | Coxiella burnetii | Amino acid biosynthesis | Aromatic amino acid family | ||||||||||||||||||||
| IDP00898 | 1 | STM2114 | 16765444 | wcaB | putative colanic acid biosynthesis acety... | 162 | Drug Target Function | March 2008 | 1T3D | 29.6% | Salmonella typhimurium | Amino acid biosynthesis | Serine family | |||||||||||||||||
| IDP01397 | 1 | VC0755 | 161582019 | aminopeptidase B | 429 | Drug Target Function | March 2008 | 1GYT | 29.8% | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01381 | 1 | VC0529 | 15640551 | ispF | 2-C-methyl-D-erythritol 2,4-cyclodiphosp... | 158 | Drug Target Function | March 2008 | 1GX1 | 74.7% | Vibrio cholerae | Biosynthesis of cofactors, prosthetic groups, and carriers | Other | |||||||||||||||||
| IDP00871 | 1 | STM1444 | 161353603 | slyA | transcriptional regulator SlyA | 144 | Drug Target Function | March 2008 | 3DEU | 97.9% | Salmonella typhimurium | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00427 | 1 | YPO4119 | 16124227 | glmU | bifunctional N-acetylglucosamine-1-phosp... | 456 | Drug Target Function | March 2008 | 1HV9 | 82.2% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP00583 | 1 | YPO2752 | 16122956 | mepA | penicillin-insensitive murein endopeptid... | 275 | Drug Target Function | March 2008 | 1TZP | 67.6% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00548 | 1 | YPO0549 | 16120877 | ftsI | penicillin-binding protein 3 | 587 | Drug Target Function | March 2008 | 3EQU | 36.6% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01428 | 1 | VC1709 | 15641713 | zinc protease, insulinase family | 922 | Drug Target Function | March 2008 | 3CWW | 19% | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01438 | 1 | VC1993 | 15641995 | 2,4-dienoyl-CoA reductase | 666 | Drug Target Function | March 2008 | 1PS9 | ||||||||||||||||||||||